Skip to content

Clinical trials

Diabetic Nephropathies trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20072
20102
20111
20121
20132
20142
20152
20161
20181
20191
20203
20213
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated5
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Keryx Biopharmaceuticals3
Boehringer Ingelheim2
Pfizer2
AstraZeneca1
Baker Heart and Diabetes Institute1
CSL Behring1
Dimerix Bioscience Pty Ltd1
Eli Lilly and Company1
Gilead Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies27
Diabetes Mellitus, Type 210
Renal Insufficiency, Chronic7
Kidney Diseases6
Albuminuria4
Diabetes Mellitus4
Diabetes Mellitus, Type 13
Glomerulonephritis, IGA3
Proteinuria3
Glomerulonephritis2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.